India · Delayed Price · Currency is INR Laxmi Organic Industries Earnings Call Transcripts
Fiscal Year 2026
-
Sequential Q4 revenue grew 9% with margin improvements, but FY2026 revenue declined 6% year-over-year due to margin pressures and deflationary feedstock prices. Specialty segment rebounded in Q4, and new capacity at Dahej is expected to drive growth in FY2027.
-
Q3 and 9M FY2026 saw revenue and EBITDA declines due to lower acetic acid prices, specialty product phase-outs, and subdued spreads, but early signs of feedstock price recovery and new capacity ramp-ups offer cautious optimism. Specialty and fluorination projects remain on track.
-
Q2 revenue declined 9% year-over-year, mainly due to a 20% drop in specialty from product phase-out, price moderation, and deferred orders. Gross margin improved to 33.1%, but EBITDA margin fell to 5.3%. New capacities and contracts are expected to drive recovery in H2 and FY2027.
-
Q1 FY26 saw a 4% revenue decline despite 8% volume growth, with Essentials up 4% and Specialities down 18% due to a product phase-out and deferred deliveries. Major CapEx projects remain on track, and supply chain digitization is underway to drive efficiency.
Fiscal Year 2025
-
Achieved 11% volume growth and improved gross margins year-on-year, with strong specialty segment performance and prudent cost management. Major projects remain on track, including Dahej and Lote, while a new LOI with Hitachi Energy opens a new market segment. Exports, capacity expansion, and innovation are key growth drivers.
-
Double-digit growth in volumes, revenues, and EBITDA was achieved year-over-year, with strong performance in both essentials and specialty segments. Major CapEx projects remain on track, and export sales now comprise 36% of total sales. Sustainability and credit ratings improved significantly.
-
Double-digit revenue and volume growth were achieved year-on-year, with EBITDA up 92% and gross margin rising to 35.8%. Major CapEx projects in essentials and specialties are on track, and the company targets sustained EBITDA and further market expansion despite ongoing weakness in agro.
-
Q1 FY2025 saw 4% year-on-year revenue growth and robust specialty segment performance, despite a scheduled maintenance shutdown impacting essentials. Strategic CapEx of INR 1,100 crore aims to double revenues and triple EBITDA by FY2028, with new projects and product launches underway.